BRIEF-Auris Medical completes patient recruitment for phase 3 trial of Keyzilen in acute and post-acute tinnitus

* Auris Medical completes patient recruitment for phase 3 TACTT3 trial of Keyzilen in acute and post-acute tinnitus
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.